These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26909392)

  • 21. Peripheral leukocyte expression of the potential biomarker proteins Bdnf, Sirt1, and Psen1 is not regulated by promoter methylation in Alzheimer's disease patients.
    Carboni L; Lattanzio F; Candeletti S; Porcellini E; Raschi E; Licastro F; Romualdi P
    Neurosci Lett; 2015 Sep; 605():44-8. PubMed ID: 26275347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum brain-derived neurotrophic factor (BDNF) and its association with remission status in Chinese patients with schizophrenia.
    Renjan V; Nurjono M; Lee J
    Psychiatry Res; 2014 Dec; 220(1-2):193-6. PubMed ID: 25174850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis.
    Green MJ; Matheson SL; Shepherd A; Weickert CS; Carr VJ
    Mol Psychiatry; 2011 Sep; 16(9):960-72. PubMed ID: 20733577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between serum brain-derived neurotrophic factor (BDNF) and cardiometabolic indices in schizophrenia.
    Nurjono M; Tay YH; Lee J
    Schizophr Res; 2014 Aug; 157(1-3):244-8. PubMed ID: 24934904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BDNF promoter methylation and genetic variation in late-life depression.
    Januar V; Ancelin ML; Ritchie K; Saffery R; Ryan J
    Transl Psychiatry; 2015 Aug; 5(8):e619. PubMed ID: 26285129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Ohta K; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aono M; Kameoka N; Sumitani S; Tomotake M; Kaneda Y; Taniguchi T; Ishimoto Y; Ohmori T
    Neurosci Lett; 2006 Jun; 401(1-2):1-5. PubMed ID: 16533563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
    Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
    World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation of BDNF as a biomarker of early-life adversity.
    Kundakovic M; Gudsnuk K; Herbstman JB; Tang D; Perera FP; Champagne FA
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6807-13. PubMed ID: 25385582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of aging on the methylation status of brain-derived neurotrophic factor gene in blood.
    Ihara K; Fuchikami M; Hashizume M; Okada S; Kawai H; Obuchi S; Hirano H; Fujiwara Y; Hachisu M; Hongyong K; Morinobu S
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1312-1318. PubMed ID: 29953671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BDNF promoter I methylation correlates between post-mortem human peripheral and brain tissues.
    Stenz L; Zewdie S; Laforge-Escarra T; Prados J; La Harpe R; Dayer A; Paoloni-Giacobino A; Perroud N; Aubry JM
    Neurosci Res; 2015 Feb; 91():1-7. PubMed ID: 25450314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia.
    Varnäs K; Lawyer G; Jönsson EG; Kulle B; Nesvåg R; Hall H; Terenius L; Agartz I
    Psychiatr Genet; 2008 Aug; 18(4):177-83. PubMed ID: 18628679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?
    Eker SS; Yavasci EO; Cangur S; Kirli S; Sarandol E
    Acta Neuropsychiatr; 2014 Oct; 26(5):291-7. PubMed ID: 25241757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine.
    Yamamori H; Hashimoto R; Ishima T; Kishi F; Yasuda Y; Ohi K; Fujimoto M; Umeda-Yano S; Ito A; Hashimoto K; Takeda M
    Neurosci Lett; 2013 Nov; 556():37-41. PubMed ID: 24141084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
    Dong E; Ruzicka WB; Grayson DR; Guidotti A
    Schizophr Res; 2015 Sep; 167(1-3):35-41. PubMed ID: 25476119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BDNF rs6265 methylation and genotype interact on risk for schizophrenia.
    Ursini G; Cavalleri T; Fazio L; Angrisano T; Iacovelli L; Porcelli A; Maddalena G; Punzi G; Mancini M; Gelao B; Romano R; Masellis R; Calabrese F; Rampino A; Taurisano P; Di Giorgio A; Keller S; Tarantini L; Sinibaldi L; Quarto T; Popolizio T; Caforio G; Blasi G; Riva MA; De Blasi A; Chiariotti L; Bollati V; Bertolino A
    Epigenetics; 2016; 11(1):11-23. PubMed ID: 26889735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain-derived neurotrophic factor epigenetic modifications associated with schizophrenia-like phenotype induced by prenatal stress in mice.
    Dong E; Dzitoyeva SG; Matrisciano F; Tueting P; Grayson DR; Guidotti A
    Biol Psychiatry; 2015 Mar; 77(6):589-96. PubMed ID: 25444166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia.
    Skilleter AJ; Weickert CS; Vercammen A; Lenroot R; Weickert TW
    Psychol Med; 2015 Mar; 45(4):841-54. PubMed ID: 25162472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor.
    Xiao W; Ye F; Liu C; Tang X; Li J; Dong H; Sha W; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():163-168. PubMed ID: 28342945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.